Provided by Tiger Trade Technology Pte. Ltd.

TEDA BIOMEDICAL

0.100
-0.019-15.97%
Volume:3.71M
Turnover:386.57K
Market Cap:213.40M
PE:-2.29
High:0.116
Open:0.115
Low:0.099
Close:0.119
52wk High:0.400
52wk Low:0.099
Shares:2.13B
HK Float Shares:1.44B
Volume Ratio:12.20
T/O Rate:0.26%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.044
ROE:-140.82%
ROA:-6.40%
PB:8.08
PE(LYR):-2.29
PS:0.31

Loading ...

Tianjin TEDA Biomedical Clarifies 4,000,000-Share Award Requires no Shareholder Approval

Reuters
·
Oct 26

Tianjin TEDA Biomedical Grants 4,000,000 Shares to Subsidiary Director Li Wanchen

Reuters
·
Oct 21

TEDA Biomedical Shareholders Authorise Board to Issue Up to 50% Additional Equity

Bulletin Express
·
Sep 24

TEDA Biomedical Swings to Profit on AI-Driven Growth; 1H26 Revenue Jumps 30.8%

Bulletin Express
·
Sep 24

TEDA Biomedical Relocates Hong Kong Principal Place of Business to Admiralty, Effective 14 September 2026

Bulletin Express
·
Sep 14

Tianjin Teda Biomedical Engineering Enters Strategic Cooperation Agreement

Reuters
·
Sep 08

TEDA BIOMEDICAL Joins Forces with Xingchen Universal to Accelerate Embodied AI in Healthcare

Stock News
·
Sep 08

Tianjin TEDA Biomedical Engineering - Parties to Jointly Promote Embodied Intelligence Scenario Open Centers, Others

THOMSON REUTERS
·
Sep 08

Tianjin TEDA Biomedical Engineering - Shenzhen Yishu Jingcheng Technology, Others Entered into Cooperation Deal

THOMSON REUTERS
·
Sep 08

Tianjin TEDA Biomedical Engineering Co - Strategic Cooperation to Focus on Public Data Operations and Industry Large Models

THOMSON REUTERS
·
Sep 08

TEDA Biomedical Schedules 24 September 2026 EGM to Seek Share Issuance Mandate

Bulletin Express
·
Sep 07

Tianjin TEDA Biomedical Engineering Announces Extraordinary General Meeting

Reuters
·
Sep 07

TEDA Biomedical Keeps Share Count Steady in August 2026, Affirms Public-Float Compliance

Bulletin Express
·
Sep 02

TEDA BIOMEDICAL Posts Interim Turnaround with Shareholder Profit of RMB 10.21 Million

Stock News
·
Aug 31

TEDA Biomedical Swings to 1H26 Profit as AI Healthcare Drives 31% Revenue Growth

Bulletin Express
·
Aug 31

Tianjin TEDA Biomedical Engineering Swings to FY26 H1 Profit of RMB 10.21 Million; Revenue Rises 30.75% to RMB 296.03 Million

Reuters
·
Aug 31

TEDA Biomedical forecasts first-half profit swing on AI healthcare growth

Stock News
·
Aug 18

TEDA Biomedical forecasts RMB290–300 million H1 revenue and swings to RMB7–10 million profit on AI healthcare growth

Bulletin Express
·
Aug 18

Tianjin TEDA Biomedical Engineering Co - Expects Net Profit of RMB7 Mln-RMB10 Mln for Six Months Ended June 30, 2026

THOMSON REUTERS
·
Aug 18

Tianjin TEDA Biomedical Engineering Co - Expects Revenue of Rmb290 Mln-Rmb300 Mln for Six Months Ended June 30, 2026

THOMSON REUTERS
·
Aug 18